← Back to Search

Couple-based intervention condition for Intervention Study (PT2T Trial)

N/A

Waitlist Available

Led By Katherine JW Baucom, PhD

Research Sponsored by University of Utah

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

1. "Target partner" is eligible for the National DPP per CDC eligibility requirements below.

A. BMI \>= 25 kg/m2 (\>= 23kg/m2 if Asian American),

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 14 months

Awards & highlights

No Placebo-Only Group

Summary

Nearly half of adults in the United States have or are at risk of developing type 2 diabetes. The overall goal of this community-engaged research is to examine the efficacy of an innovative couple-based lifestyle intervention to prevent type 2 diabetes that is applicable to a broad range of partnered adults in the United States. By simultaneously targeting lifestyle and perceived support from romantic partners, there is a high likelihood of creating lasting changes in both

Eligible Conditions

Intervention Study
Social Support
Incretin Hormones in Polycystic Ovary Syndrome
Prediabetes
Obesity
Lifestyle
Physical Activity

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 14 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~14 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 14 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Percent of target partners achieving clinically meaningful increases in Moderate to Vigorous Physical Activity (MVPA)

Secondary study objectives

HbA1c

Nutrition

Perceived Partner Support

+3 more

Other study objectives

Additional lifestyle intervention engagement

Anxiety

Communal Coping

+14 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Couple-based intervention conditionExperimental Treatment1 Intervention

"PreventT2 Together" (couple-based adaptation of PreventT2; approved by the CDC in November 2022 as an Alternate Curriculum for use in the National DPP)

Group II: Individual intervention conditionActive Control1 Intervention

"PreventT2" individual lifestyle intervention curriculum (2021 revised National DPP curriculum, freely available from the CDC)

0 / 10Eligibility criteria met